Cargando…

Prognostic value of KRAS subtype in patients with PDAC undergoing radical resection

OBJECTIVE: To explore the frequency distribution of KRAS mutant subtypes in patients with resectable PDAC in China and then evaluate the prognostic value of different KRAS subtypes in patients with PDAC undergoing radical resection. METHODS: The clinicopathological data and gene test reports of 227...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Manxiong, Jahanzaib, Raja, Liao, Yan, Yao, Fengxuan, Li, Jia, Teng, Xiong, Chen, Kang, Cheng, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793713/ https://www.ncbi.nlm.nih.gov/pubmed/36582783 http://dx.doi.org/10.3389/fonc.2022.1074538

Ejemplares similares

Prognostic Value of an Immunohistochemical Signature in Patients With Bladder Cancer Undergoing Radical Cystectomy
por: Wu, Jie, et al.
Publicado: (2021)

KRAS as a Key Oncogene in the Clinical Precision Diagnosis and Treatment of Pancreatic Cancer
por: Dai, Manxiong, et al.
Publicado: (2022)

Mitochondria Dysfunction-Mediated Molecular Subtypes and Gene Prognostic Index for Prostate Cancer Patients Undergoing Radical Prostatectomy or Radiotherapy
por: Feng, Dechao, et al.
Publicado: (2022)

Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypes
por: Schlitter, Anna Melissa, et al.
Publicado: (2017)

Targeting KRAS in PDAC: A New Way to Cure It?
por: He, Qianyu, et al.
Publicado: (2022)

The role of BHLHE40 in clinical features and prognosis value of PDAC by comprehensive analysis and in vitro validation
por: Liu, Chao, et al.
Publicado: (2023)

Prognostic Value of Gamma-Glutamyl Transpeptidase to Lymphocyte Count Ratio in Patients With Single Tumor Size ≤ 5 cm Hepatocellular Carcinoma After Radical Resection
por: Liao, Minjun, et al.
Publicado: (2019)

BET inhibition is an effective approach against KRAS-driven PDAC and NSCLC
por: Jauset, Toni, et al.
Publicado: (2018)

Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer
por: Lavacchi, Daniele, et al.
Publicado: (2022)

Prognostic Value of the Systemic Inflammatory Response Index in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Population-Based Study
por: Ni, Jinliang, et al.
Publicado: (2021)

The Value of Perioperative Chemotherapy for Patients With Hepatoid Adenocarcinoma of the Stomach Undergoing Radical Gastrectomy
por: Zhou, Kai, et al.
Publicado: (2022)

Prognostic Value of Preoperative Hydronephrosis in Patients Undergoing Radical Nephroureterectomy for Upper Tract Urinary Carcinoma: A Systematic Review and Meta-Analysis
por: Ye, Tao, et al.
Publicado: (2020)

Prognostic Value of Lymphocyte–C-Reactive Protein Ratio in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Population-Based Study
por: Zhang, Houliang, et al.
Publicado: (2021)

The value of ICG-guided left colon vascular variation and anatomical rules for the radical resection of proctosigmoid colon cancer
por: Wang, Jiahao, et al.
Publicado: (2023)

Analysis of the clinical efficacy of laparoscopic middle pancreatectomy in the treatment of benign or low-grade malignant tumors of the pancreas
por: Liao, Yan, et al.
Publicado: (2023)

Preoperative detection of KRAS G12D mutation in ctDNA is a powerful predictor for early recurrence of resectable PDAC patients
por: Guo, Shiwei, et al.
Publicado: (2020)

Linear Skeletal Muscle Index and Muscle Attenuation May Be New Prognostic Factors in Colorectal Carcinoma Treated by Radical Resection
por: Wang, Yang, et al.
Publicado: (2022)

Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
por: Pervin, Jannat, et al.
Publicado: (2023)

A population-based study of synchronous distant metastases and prognosis in patients with PDAC at initial diagnosis
por: Zhang, Leiming, et al.
Publicado: (2023)

Genome-wide identification of A-to-I RNA editing events provides the functional implications in PDAC
por: Mei, Yue, et al.
Publicado: (2023)

The immunomodulatory role of IDO1-Kynurenine-NAD(+) pathway in switching cold tumor microenvironment in PDAC
por: Anu, R. I., et al.
Publicado: (2023)

Adjuvant transarterial chemoembolization timing after radical resection is an independent prognostic factor for patients with hepatocellular carcinoma
por: Sun, Hongfa, et al.
Publicado: (2023)

Prognostic Value of the Lymph Node Ratio in Stage III Gastric Cancer Patients Undergoing Radical Resection
por: Ke, Bin, et al.
Publicado: (2014)

Preoperative Serum Gamma-Glutamyltransferase as a Prognostic Biomarker in Patients Undergoing Radical Cystectomy for Bladder Cancer
por: Su, Shiqiang, et al.
Publicado: (2021)

Characteristics and prognostic values of traditional pathological parameters and advanced molecular subtypes in women in Beijing with operable breast cancer: a retrospective analysis
por: Li, Qin, et al.
Publicado: (2018)

The PDAC Extracellular Matrix: A Review of the ECM Protein Composition, Tumor Cell Interaction, and Therapeutic Strategies
por: Perez, Vincent M., et al.
Publicado: (2021)

Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma
por: Khadse, Anand, et al.
Publicado: (2022)

Prognostic analysis of radical resection for iCCA(phl) and iCCA(pps): A retrospective cohort study
por: Yu, Zetao, et al.
Publicado: (2022)

Interdisciplinary Approach of Establishing PDAC Resectability: Biochemical, Radiological and NAT Regimen Prognostic Factors—Literature Review
por: Gulla, Aiste, et al.
Publicado: (2022)

Construction a new nomogram prognostic model for predicting overall survival after radical resection of esophageal squamous cancer
por: Shi, Bowen, et al.
Publicado: (2023)

Feasibility of a CT-based lymph node radiomics nomogram in detecting lymph node metastasis in PDAC patients
por: Li, Qian, et al.
Publicado: (2022)

Prognostic and therapeutic impact of the KRAS G12C mutation in colorectal cancer
por: Qunaj, Lindor, et al.
Publicado: (2023)

Prognostic Value of Serum Osteoprotegerin Level in Patients With Hepatocellular Carcinoma Following Surgical Resection
por: Zhang, Chihao, et al.
Publicado: (2021)

Prognostic Nomograms Combined Adjuvant Lenvatinib for Hepatitis B Virus–related Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection
por: Bai, Shilei, et al.
Publicado: (2022)

The prognostic value of tumor length to resectable esophageal squamous cell carcinoma: a retrospective study
por: Zhang, Xiangwei, et al.
Publicado: (2017)

Prognostic Significance of NLR, PLR, LMR and Tumor Infiltrating T Lymphocytes in Patients Undergoing Surgical Resection for Hilar Cholangiocarcinoma
por: Lin, Zhi-qiang, et al.
Publicado: (2022)

Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer
por: Wang, Fang, et al.
Publicado: (2018)

Preoperative lung immune prognostic index predicts survival in patients with pancreatic cancer undergoing radical resection
por: Zhou, Qian, et al.
Publicado: (2023)

AHNAK2 is a potential prognostic biomarker in patients with PDAC
por: Lu, Di, et al.
Publicado: (2017)

Splenosis in patient undergoing robotic assisted laparoscopic radical prostatectomy
por: Sykes, Jennifer, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qlc4f8jkar76r9j3pv3ce39gtp